Residual malignant and normal plasma cells shortly after high dose melphalan and stem cell transplantation. Highlight of a putative therapeutic window in Multiple Myeloma?

Multiple Myeloma (MM) is an incurable malignant plasma cell disorder. We have evaluated the counts of Multiple Myeloma Cells (MMCs) and normal plasma cells (N-PCs), seven days after high-dose melphalan (HDM) and autologous stem transplantation (ASCT). Two third of patients had detectable minimal res...

詳細記述

保存先:
書誌詳細
出版年:Oncotarget
主要な著者: Caraux, Anouk, Vincent, Laure, Bouhya, Salahedine, Quittet, Philippe, Moreaux, Jérôme, Requirand, Guilhem, Veyrune, Jean-Luc, Olivier, Gaëlle, Cartron, Guillaume, Rossi, Jean-François, Klein, Bernard
フォーマット: Artigo
言語:Inglês
出版事項: Impact Journals LLC 2012
主題:
Research Paper
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4539173/
https://ncbi.nlm.nih.gov/pubmed/23154454
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料